TRIN molecules to be clinically investigated soon.

TRIN 2755
Development candidate for treatment of melanoma, breast cancer and colon cancer. Entry of the lead candidate TRIN 2755 into clinical studies is scheduled for Q 4/2009

TRIN 2758
Back-up candidate to TRIN 2755

TRIN 2750
On-going pharmacological profiling based on selective anti-tumor activity. Target tumor for clinical development to be defined